Perlegen Outlines Collaboration With Pfizer
This article was originally published in The Pink Sheet Daily
Executive Summary
Companies to engage in four-year research project on genomic markers.
You may also be interested in...
Pfizer Boosts Pharmacogenomic Pedigree With $50 Mil. Stake In Perlegen
Biotech company specializes in identifying genetic markers to predict patient response to drugs.
Future BIO Global Efforts Include International Relations, Greenwood Says
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13
Hospira’s Mayne Event: Acquisition Strengthens Oncology Portfolio
Merger will create the leading generic injectable pharmaceutical company in the world.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: